UK Medtech Industry Seeking More Clarity On Restart Of Elective Procedures
COVID-19 led to a significant reduction in elective procedures carried out by the UK NHS, broke referral pathways, and put a virtual halt to diagnostics and screening programs. The likely next stages and the concerns of the medtech sector are top priorities for the ABHI.
You may also be interested in...
Corin has transformed from a niche UK hip resurfacing company into an innovative global player in orthopedics with a portfolio that includes robotics. UK managing director Paul Gibbons explained the group’s approach to business during COVID-19, and its culture of innovation.
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
Residual resistance to digital health care solutions in the UK NHS disappeared “almost overnight” when COVID-19 compelled the rapid adoption of new tools to meet the surge in demand and cope with supply challenges.